ARK GENOMIC REVOLUTION ETF | ARKG

Medium RiskARKGMorning Star5 / 5
ARK GENOMIC REVOLUTION ETF
Issued by:ARK Investment Management LLC
Unit Price (NAV) : $
Minimum investment: 2 units
Share
Compare
Share
Compare
ARK GENOMIC REVOLUTION ETF | ARKG

ARK GENOMIC REVOLUTION ETF | ARKG

About ARKG ETF

Overview:
ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • CRISPR
  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:
Growth

ARKG ChartsLifetime25.99%
ARKG Performance1Y3Y5Y
This ETF59.97%38.26%20.92%

Projected Returns

Investment ofper month
gives returns of :
at 20.92% / annum
$in 5 years
amount
for a time period of
time1Y3Y5Y
Returns % (CAGR)based on historic returns of 20.92% per annum
$
$
$+ 20.92%

Asset Class

Asset type breakdown
Stock US80.11%
Stock non-US19.51%
Cash0.38%

ARKG Holdings - Top 10

NameiWeightage (%)
Invitae Corporation11.79%
CRISPR Therapeutics AG11.23%
Arcturus Therapeutics Holdings Inc6.44%
Illumina, Inc5.36%
Compugen Ltd5.17%
Twist Bioscience Corporation3.80%
CareDx, Inc3.55%
Iovance Biotherapeutics, Inc3.52%
Intellia Therapeutics, Inc3.43%
Editas Medicine, Inc3.29%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Healthcare97.17%
Technology2.55%
Consumer Defensive0.28%

ARKG Countries

Country% of market value
North America80.42%
Europe Developed13.06%
Africa/Middle East6.53%

ARKG Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Morningstar Ratings 5i
Symbol ARKG
Exchange ARCX
Asset class ARKG

ARKG Portfolio Data & Volatility Analysis

Expense ratio 0.75i
Beta 1.58i
P/E ratio 62.96794i
Standard Deviation 36.37i
ARK GENOMIC REVOLUTION ETF | ARKG